Sandostatin and Bile duct obstruction - a phase IV clinical study of FDA data
Bile duct obstruction is found among people who take Sandostatin, especially for people who are male, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Sandostatin and have Bile duct obstruction. It is created by eHealthMe based on reports of 45,110 people who have side effects when taking Sandostatin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
45,110 people reported to have side effects when taking Sandostatin.
Among them, 274 people (0.61%) have Bile duct obstruction.
What is Sandostatin?
Sandostatin has active ingredients of octreotide acetate. It is often used in acromegaly. eHealthMe is studying from 45,210 Sandostatin users for its effectiveness, alternative drugs and more.
What is Bile duct obstruction?
Bile duct obstruction (blockage in the tubes that carry bile from the liver to the gallbladder) is found to be associated with 1,245 drugs and 595 conditions by eHealthMe.
Number of Sandostatin and Bile duct obstruction reports submitted per year:
Time on Sandostatin when people have Bile duct obstruction *:
Gender of people who have Bile duct obstruction when taking Sandostatin*:
Age of people who have Bile duct obstruction when taking Sandostatin *:
Common drugs people take besides Sandostatin *:
Common side effects people have besides Bile duct obstruction *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Sandostatin and have Bile duct obstruction?Check whether Bile duct obstruction is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Saif MW, "Rheumatoid arthritis associated with the use of Sandostatin? LAR? depot in a patient with pancreatic neuroendocrine tumor", An association or a coincidence? The first case report, 2017 Jan .
- Azkur D, Yoldas T, Toyran M, Kocabas CN, "A pediatric case of anaphylaxis due to octreotide", Asian Pacific journal of allergy and immunology, 2011 Dec .
How severe was Bile duct obstruction and when was it recovered:
Expand to all the drugs that have ingredients of octreotide acetate:
Alternative drugs to, pros and cons of Sandostatin:
- Sandostatin (45,210 reports)
Common Sandostatin side effects:
- Diarrhea: 9,954 reports
- High blood pressure: 9,507 reports
- Fatigue (feeling of tiredness): 8,310 reports
- Malaise (a feeling of general discomfort or uneasiness): 6,786 reports
- Pain: 5,987 reports
Browse all side effects of Sandostatin:a b c d e f g h i j k l m n o p q r s t u v w x y z
Bile duct obstruction treatments and more:
- Bile duct obstruction (3,581 reports)
COVID vaccines that are related to Bile duct obstruction:
- Bile duct obstruction in Moderna COVID Vaccine
- Bile duct obstruction in Pfizer BioNTech Covid Vaccine
- Bile duct obstruction in Johnson and Johnson Covid Vaccine
Common drugs associated with Bile duct obstruction:
- Sandostatin: 274 reports
- Prednisone: 268 reports
- Humira: 259 reports
- Sandostatin lar: 204 reports
- Aspirin: 162 reports
- Omeprazole: 152 reports
- Methotrexate: 151 reports
- Morphine: 122 reports
- Metformin: 104 reports
All the drugs that are associated with Bile duct obstruction:
- Bile duct obstruction (1,245 drugs)
Common conditions associated with Bile duct obstruction:
- Rheumatoid arthritis: 232 reports
- High blood pressure: 172 reports
- Type 2 diabetes: 141 reports
- Pain: 114 reports
- Multiple sclerosis: 110 reports
All the conditions that are associated with Bile duct obstruction:
- Bile duct obstruction (595 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on octreotide acetate (the active ingredients of Sandostatin) and Sandostatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ceftazidime and Staphylococcal Infection - 14 seconds ago
- Sodium Bicarbonate and Quinine Sulfate drug interaction - 17 seconds ago
- Lumigan and Diprolene drug interaction - 18 seconds ago
- Jardiance and Oedema Aggravated - 20 seconds ago
- Methylprednisolone Sodium Succinate and Hypertrophic Cardiomyopathy - 24 seconds ago
- Desogestrel And Ethinyl Estradiol and Electrocardiogram Qt Corrected Interval Prolonged - 31 seconds ago
- Hydralazine Hydrochloride and Micardis drug interaction - 33 seconds ago
- Ampyra and Prochlorperazine drug interaction - 38 seconds ago
- Miralax and Viramune Xr drug interaction - 45 seconds ago
- Naprosyn vs. Opana - 54 seconds ago